ArticleMolecular biology of the cell2026
David Baltimore and the advent of eukaryotic RNA-binding proteins.
Article in Molecular biology of the cell, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The late David Baltimore will long be remembered as a towering figure in the modern era of virology and immunology. But less well known is that early in his career, he discovered the existence of eukaryotic RNA-binding proteins, in collaboration with Alice Huang. This work was an extension of previous experiments he had done in which poliovirus RNA added to HeLa cell cytoplasmic extracts underwent an increase in its sucrose gradient sedimentation velocity. The subsequent work revealed the existence of a soluble pool of RNA-binding proteins and had two impacts. On the one hand, it was the beginning of the eukaryotic RNA-binding protein field. On the other hand, it led some investigators to challenge the reality of isolated mRNP complexes. As we know, the latter concern was settled by the introduction of in vivo UV-mediated RNA-protein crosslinking. The mRNA-protein interaction landscape now is at a very advanced and richly enabling stage, but as always in scientific epistemology, it is appropriate to recall from whence it arose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.